Signos

Company Overview

Signos is the first FDA-cleared metabolic health platform that helps employees understand and improve their metabolism in real-time, providing employers with the data to make informed benefits decisions.Powered by Dexcom’s Stelo CGM and AI-driven guidance, Signos turns glucose data into personalized, actionable recommendations that support sustainable weight management and better metabolic health. For employers, this means healthier populations, reduced reliance on GLP-1 medications, and more predictable benefit costs through data-driven, predictive health.

Founded

2018

Headquarters

—

Employees

11-50

20.6% growth last 12mo

Marketing Team

19

16% of company

Culture / Work-Life Signal

Overall rating

0 / 5

Work-life balance

0 / 5

Culture

0 / 5

Diversity & inclusion

0 / 5

Recommend to a friend

0%

Positive business outlook

0%

Overall Headcount Trend

Overall Headcount Trend

Company growth over the last 12 months

Salaries

Job Posting Salary Data

From 1 marketing roles posted in the last 12 months

Typical Salary Range

$110,000 – $130,000

YEAR

100%

share salary

Community Salary Data

Help build salary transparency at Signos. Share your compensation anonymously.

Reviews

Rate This Company

Share your experience working here including compensation, culture, and work-life balance.

News

Signos CEO Sharam Fouladgar-Mercer talks first FDA-approved glucose monitor for weight loss

Sep 10, 2025 • CNBC

Signos Launches First FDA-Cleared Glucose Monitoring System for Weight Management

Sep 8, 2025 • HIT Consultant

Signos launches first FDA-cleared over-the-counter glucose monitoring system for weight management

Aug 25, 2025 • Medical Economics

Jobs

We don't have job postings for Signos yet. Help build transparency by contributing.

Contribute data